Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.

Clinical trial NCT05789771 · COMPLETED

Trial details

NCT number: NCT05789771
Sponsor: Blokhin's Russian Cancer Research Center
Status: COMPLETED
Study type: OBSERVATIONAL

HR+/HER2- Breast Cancer Metastatic Disease Аdvanced Disease

Start date: 2022-04-01
Primary completion: 2022-12-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.